| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482212C Process for preparing nano liposome for coating large molecular medicine |
| 04/29/2009 | CN100482207C Novel lipid mixtures for synthetic surfactants |
| 04/28/2009 | US7524981 Phospholipid derivatives and process for the production there |
| 04/28/2009 | US7524940 OB protein compositions and methods |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524680 Polyampholytes for delivering polyions to a cell |
| 04/28/2009 | US7524661 Product R; for treating viral infections and stimulating the immune system; immune system disorders |
| 04/28/2009 | US7524530 Combining exendin and sucrose with oil phase comprising glycolic acid-lactic acid copolymer in methylene chloride to form emulsion, which is combined with coacervation agent (silicone oil) to form microparticles, transferring to quenching solvent, then hardening; sustained release; shelf life |
| 04/28/2009 | US7524524 For low fat spreads; fractionation, interesterification of blends of stearic acid and palmitic acid |
| 04/28/2009 | US7524513 Polymeric fibers with conjugated biofunctional ligands and/or cell factors with biodegradation or nonbiodegradation fibers |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | US7524478 Neutralizing aqueous alkali silicate solution then simultaneously increasing silicate concentration and acidifying; filtering dispersion and drying |
| 04/28/2009 | CA2496864C A pharmaceutical composition |
| 04/28/2009 | CA2486883C Method of manufacturing sertindole |
| 04/28/2009 | CA2450949C Methods and compositions for polyene antibiotics with reduced toxicity |
| 04/28/2009 | CA2438199C Process for making microcapsules involving phase inversion |
| 04/28/2009 | CA2425314C Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/28/2009 | CA2408245C Media milling |
| 04/28/2009 | CA2394672C Biodegradable polymer composition |
| 04/28/2009 | CA2361716C Method of preparing alkylated salicylamides |
| 04/28/2009 | CA2361424C Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 04/28/2009 | CA2360236C Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 04/28/2009 | CA2339765C Compounds and compositions for delivering active agents |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/28/2009 | CA2164838C A lotion comprising a tricyclic macrolide |
| 04/23/2009 | WO2009052435A1 Anti-tnfri polypeptides and their uses |
| 04/23/2009 | WO2009052249A1 Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 04/23/2009 | WO2009051217A1 Fentanyl-containing percutaneous absorption preparation |
| 04/23/2009 | WO2009050720A1 Pharmaceutical composition of orlistat |
| 04/23/2009 | WO2009050555A2 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 04/23/2009 | WO2009050527A1 Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide |
| 04/23/2009 | WO2009050490A1 Oral composition comprising a cooling agent |
| 04/23/2009 | WO2009050483A1 Cationic lipids |
| 04/23/2009 | WO2009050405A1 Novel compounds prepared by adding an oxetane derivative to an alcohol |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050372A2 Compositions containing lipophosphoramides and use thereof in gene therapy |
| 04/23/2009 | WO2009050333A1 Microencapsulated liposomal compositions |
| 04/23/2009 | WO2009049820A2 Amorphous formulation |
| 04/23/2009 | WO2009049648A2 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof |
| 04/23/2009 | WO2009024670A3 Hyaluronic acid injectable gel for treating joint degeneration |
| 04/23/2009 | WO2009023473A9 Antimicrobial parenteral formulation |
| 04/23/2009 | WO2008141107A3 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 04/23/2009 | WO2008074487A3 Lipids and lipid assemblies comprising transfection enhancer elements |
| 04/23/2009 | WO2006105123A3 Peg-polyacetal diblock and triblock copolymers and pharmaceutical compositions |
| 04/23/2009 | WO2006098767A3 Treatment of adhd |
| 04/23/2009 | WO2006037113A3 Multifunctional supramolecular hydrogels as biomaterials |
| 04/23/2009 | US20090105461 Calicheamicin conjugates |
| 04/23/2009 | US20090105353 Cosmetic oil-in-water emulsion |
| 04/23/2009 | US20090105352 Functionalized biodegradable triclosan monomers and oligomers for controlled release |
| 04/23/2009 | US20090105351 Micellar drug delivery systems for hydrophobic drugs |
| 04/23/2009 | US20090105331 Compositions of active ingredients |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105183 Pharmaceutical composition containing decoy and method of using the same |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104291 Water-dispersible nanoparticle which contains blood circulation promoter |
| 04/23/2009 | US20090104270 Film delivery system for tetrahydrolipstatin |
| 04/23/2009 | US20090104263 5-HT4 partial agonist pharmaceutical compositions |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104251 Heat stable microcapsules and methods for making and using the same |
| 04/23/2009 | US20090104247 Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings |
| 04/23/2009 | US20090104245 makes it possible to add viruses as biologically active agents into a biodegradable gel so that viruses do not loose their activity to infect and/or transfect cells; for controlled delivery of biologically active agents where said biodegradable carrier is a silica xerogel |
| 04/23/2009 | US20090104237 Method for increasing tissue oxygenation |
| 04/23/2009 | US20090104223 Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104183 Glue composition for lung volume reduction |
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104143 Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells |
| 04/23/2009 | US20090104134 Organophilic clay for thickening organic solvents |
| 04/23/2009 | US20090104129 Skin care compositions |
| 04/23/2009 | US20090104127 Suspension aerosol formulations of pharmaceutical products |
| 04/23/2009 | US20090104119 Dendrimer Based Compositions And Methods Of Using The Same |
| 04/23/2009 | CA2703002A1 Bowel purgative and uses thereof |
| 04/23/2009 | CA2702935A1 Solid formulations of crystalline compounds |
| 04/23/2009 | CA2702892A1 An orally administerable solid pharmaceutical composition and a process thereof |
| 04/23/2009 | CA2702862A1 Cationic lipids |
| 04/23/2009 | CA2702688A1 Oral composition comprising a cooling agent |
| 04/23/2009 | CA2702614A1 Composition for administering an active ingredient and method for making and using the same |
| 04/23/2009 | CA2701037A1 New lipophilic compositions and their uses |
| 04/23/2009 | CA2698541A1 Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 04/22/2009 | EP2051075A1 Particles |
| 04/22/2009 | EP2050473A1 Drug delivery device |
| 04/22/2009 | EP2050465A2 Compositions comprising the adjuvant QS-21 and polysorbate or cyclodextrin as excipient |
| 04/22/2009 | EP2050456A1 Tablet |
| 04/22/2009 | EP2050449A1 Aqueous liquid preparation containing amide compound |
| 04/22/2009 | EP2050448A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 04/22/2009 | EP2050445A2 Pharmaceutical composition of phenofibrate with high bioavailability and method for preparing same |
| 04/22/2009 | EP2050439A1 Process for production of spherical granule containing slightly water-soluble substance |
| 04/22/2009 | EP2050438A1 Spherical crude granule and method for production thereof |
| 04/22/2009 | EP2050435A1 Cough mixture |
| 04/22/2009 | EP2049566A1 G-csf site-specific mono-conjugates |
| 04/22/2009 | EP2049157A2 Polymeric conjugates of doxorubicin with ph-regulated release of the drug and a method of preparing |
| 04/22/2009 | EP2049149A2 Pegylated extended insulins |
| 04/22/2009 | EP2049148A1 A stable liquid formulation of human growth hormone |